Login / Signup

MutaT7 GDE : A Single Chimera for the Targeted, Balanced, Efficient, and Processive Installation of All Possible Transition Mutations In Vivo .

Amanuella A MengisteJulie L McDonaldMinh Thuan Nguyen TranAnna V PlankRobert H WilsonVincent L ButtyMatthew D Shoulders
Published in: ACS synthetic biology (2024)
Deaminase-T7 RNA polymerase fusion (MutaT7) proteins are a growing class of synthetic biology tools used to diversify target genes during in vivo laboratory evolution. To date, MutaT7 chimeras comprise either a deoxyadenosine or deoxycytidine deaminase fused to a T7 RNA polymerase. Their expression drives targeted deoxyadenosine-to-deoxyguanosine or deoxycytidine-to-deoxythymidine mutagenesis, respectively. Here, we repurpose recently engineered substrate-promiscuous general deaminases (GDEs) to establish a substantially simplified system based on a single chimeric enzyme capable of targeting both deoxyadenosine and deoxycytidine. We assess on- and off-target mutagenesis, strand and context preference, and parity of deamination for four different MutaT7 GDE constructs. We identify a single chimera that installs all possible transition mutations more efficiently than preexisting, more cumbersome MutaT7 tools. The optimized MutaT7 GDE chimera reported herein is a next-generation hypermutator capable of mediating efficient and uniform target-gene diversification during in vivo directed evolution.
Keyphrases
  • cancer therapy
  • crispr cas
  • genome wide
  • poor prognosis
  • cell therapy
  • drug delivery
  • copy number
  • mesenchymal stem cells
  • dna methylation
  • structural basis